The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Long‐term follow‐up of bone mineral density and bone metabolism in transsexuals treated with cross‐sex hormones
Abstract
OBJECTIVE: It is unknown whether long term cross‐sex hormone treatment affects the human skeleton. We monitored bone mineral density and biochemical markers of bone turnover for 28–63 months in 20 male‐to‐female transsexuals (M → F) treated with anti‐androgens and oestrogens, and 19 female‐to‐male transsexuals (F → M) treated with androgens. They underwent gonadectomy 13–35 months after the start of cross‐sex hormone administration. DESIGN: Bone mineral density (BMD) and the markers of bone turnover osteocalcin, alkaline phosphatase, fasting urinary calcium/creatinine and hydroxyproline/creatinine, were measured at baseline, after 1 year and after 28–63 months of cross‐sex hormone administration. RESULTS: In oestrogen‐treated M → F, variables of bone turnover decreased significantly with consecutive measurements. BMD had increased significantly after 1 year, but decreased again to baseline levels after 28–63 months of cross‐sex hormones. In F → M, alkaline phosphatase levels increased during the first year. BMD did not change during the first year but had decreased significantly after 28–63 months following ovariectomy. In both M → F and F → M, the change of BMD correlated inversely with serum LH and FSH levels. Of all biochemical variables LH levels appeared to be the best predictor of loss of BMD; in the long‐term LH levels were more elevated in testosterone‐treated F → M than in oestrogen‐treated M → F transsexuals. CONCLUSION: In M → F, oestrogen treatment prevented bone loss after testosterone deprivation. In F → M the testosterone dosage used, associated with a decline in serum oestradiol levels, was unable to maintain bone mass fully in all subjects in the longer term. The inverse relationship between BMD and serum LH levels suggests that the dose of hormone replacement has been too low in subjects with a decline in their BMD. Its cause might be underdosing or non‐compliance in some patients. We propose that serum LH levels may be used as a measure of the adequacy of replacement with sex steroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151
CHRISTIANSEN, C., CHRISTENSEN, M. S., LARSEN, N.-E., & TRANSBØL, I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-6-1124 · Cited by 209
Dr. Diamond, T., Stiel, D., & Posen, S. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060108 · Cited by 96 · cited 1×
“Sex hormone replacement therapy has been shown to prevent further loss (Recker et al., 1977; Finkelstein et al., 1989; Diamond et al., 1991; Felson et al., 1993; Gulekli et al., 1994; Aitken et al., 1995).”
Background
Cited by
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328
Self-citationEndocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0345 · Cited by 1,026
Self-citationVanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action1
Grumbach, M. M., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6290 · Cited by 368
Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons
Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., & T’Sjoen, G. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02876.x · Cited by 335
Metadata
- Authors
- Van Kesteren, P., Lips, P., Gooren, L. J. G., Asscheman, H., & Megens, J.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1998-03
- Volume
- 48
- Issue
- 3
- Pages
- 347-354
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2118931485
- Cited by
- 181
- References
- 3
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long‐term follow‐up of bone mineral density and bone metabolism in transsexuals treated with cross‐sex hormones. https://app.cochat.ai/papers/10.1046/j.1365-2265.1998.00396.x
- The paper
- Van Kesteren, P., Lips, P., Gooren, L. J. G., Asscheman, H., & Megens, J. (1998). Long‐term follow‐up of bone mineral density and bone metabolism in transsexuals treated with cross‐sex hormones. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1998.00396.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.